Formoterol
Back to searchMolecule Structure
Scientific Name
Formoterol
Description of the Drug
Formoterol is an inhaled long-acting beta2-adrenergic receptor agonist used as a bronchodilator in the management of asthma and COPD.
Source: DrugBank Online – DrugBank.com. Retrieved 2023-03-10 from
http://www.drugbank.ca/drugs/DB00983
http://www.drugbank.ca/drugs/DB00983
Brand Name(s)
Not Available
Company Owner(s)
Teva Pharmaceuticals Usa Inc, Astrazeneca Ab, Alembic Pharmaceuticals Ltd, Organon Llc, Lupin Inc, Covis Pharma Gmbh, Astrazeneca Pharmaceuticals Lp, Mylan Specialty Lp, Mylan Pharmaceuticals Inc, Novartis Pharmaceuticals Corp
Mechanism(s) Of Action
| Target Name | Target Type | Action Type | Target ChEMBL ID |
|---|---|---|---|
| Beta-2 adrenergic receptor | SINGLE PROTEIN | AGONIST | CHEMBL210 |
Clinical Trial(s)
Unichem Links
| SureChEMBL | SCHEMBL349579 | ||||
| PharmGKB | PA134687907 | ||||
| Human Metabolome Database | HMDB0015118 | ||||
| DrugBank | DB00983 | ||||
| PubChem: Thomson Pharma | 14875897 | ||||
| PubChem | 3410 | ||||
| BindingDB | 86453 | ||||
| DrugCentral | 1239 | ||||
| Guide to Pharmacology | 3465 | ||||
| rxnorm | PERFOROMIST | FORMOTEROL FUMARATE DIHYDRATE | FORMOTEROL | FORADIL | FORMOTEROL FUMARATE |
| KEGG Ligand | C07805 | ||||
| ChEBI | 63082 |
